Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV

Vesicular stomatitis virus (VSV) remains an attractive platform for a potential HIV-1 vaccine but hurdles remain, such as selection of a highly immunogenic HIV-1 Envelope (Env) with a maximal surface expression on recombinant rVSV particles. An HIV-1 Env chimera with the transmembrane domain (TM) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Hiva, Knapp, Jason P., Li, Yue, Berger, Alice, Lafrance, Marc-Alexandre, Pedersen, Jannie, de la Vega, Marc-Antoine, Racine, Trina, Kang, Chil-Yong, Mann, Jamie F. S., Dikeakos, Jimmy D., Kobinger, Gary, Arts, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223473/
https://www.ncbi.nlm.nih.gov/pubmed/37243081
http://dx.doi.org/10.3390/vaccines11050977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223473/
https://www.ncbi.nlm.nih.gov/pubmed/37243081
http://dx.doi.org/10.3390/vaccines11050977

Ejemplares similares